您的位置: 首页 > 农业专利 > 详情页

ANTITUMOR PEPTIDE DERIVED FROM A COMPLEMENTARITY DETERMINING REGION OF A HUMANIZED MONOCLONAL ANTIBODY TO NAPI2B TRANSPORTER
专利权人:
Recepta Biopharma S.A.
发明人:
TRAVASSOS, Luiz, Rodolpho, Raja, Gabaglia
申请号:
EP11849571
公开号:
EP2654769A4
申请日:
2011.12.14
申请国别(地区):
EP
年份:
2017
代理人:
摘要:
Described herein is novel isolated or synthetic peptides derived from a complementarity determining region hypervariable domain amino acid sequence of a humanized monoclonal antibody to NaPi2B transporter, as well as derivatives thereof, and a pharmaceutical composition and a method for inhibiting tumor growth or treating a tumor or cancer treating using the antitumor peptides and derivatives thereof.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充